Market value ranking of global pharmaceutical companies in 2015

Source: Cypress Blue / Banxia 2015-10-08 September 28, Gen website announced the top 10 pharmaceutical companies with the highest market value in 2015 This year, Johnson & Johnson regretted that he failed to defend his title, while Roche's previous runner up position was not maintained, and AstraZeneca failed to make the list! Novartis, on the other hand, went from third to top Compared with the market value of the top ten pharmaceutical companies listed by Gen last year, the total market value of the four giants GlaxoSmithKline, Johnson & Johnson, MSD and Roche has decreased this year, while the market value of the other five companies - Alberto, Bayer, Novartis, Pfizer and Sanofi has increased year on year AstraZeneca, which was on the list last year, missed the chance to be on the list this year because of the serious market value decline this year On the contrary, Bristol Myers Squibb has grown in market value this year and become the top ten newcomers Note: the market value is calculated by multiplying the stock price by the current market price Appendix: the total market value of the top 10 pharmaceutical companies in 2015 has shrunk in the past year In fact, to some extent, it is also affected by biotechnology companies With the continuous expansion of market demand, the market share of biotechnology companies has increased dramatically In September, Gen also released a list of the top 25 biotech companies by market value Among them, Gillette, Novo Nordisk, Allergan and Amgen are the leading groups, especially Allergan, whose market value has increased by more than 50% compared with last year It is worth mentioning that Sinopharm holdings, as the only domestic enterprise, is also on the top 25 list Attached: "2015 Biotech Corp market value Top25 list" (Note: the above data are from GEN website)